THE CALANDRA REPORT: Subscribe $91 yearly SAN DIEGO — Inovio Pharmaceuticals (INO in USA), a DNA vaccine developer I sidestepped for four years, is having success with a Middle Eastern virus. INO shares are raging today. Inovio’s J, Joseph Kim, via a persistent biz-dev executive, Bernie Hertel, has been on me, professionally, since 2009. Inovio… Continue Reading
Warke, Telfer, Giustra Take Over Tiny Catalyst Copper
3 Reasons Gold Miners are Ready to Rip
Trouble in Bond Land
How to Get an MBA from Eminem?
INDUSTRY REPORT: The Weekly Dig - July 18, 2014